A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.
Hiroshi KasamatsuTakenao ChinoTakumi HasegawaNatsuko UtsunomiyaAkira UtsunomiyaMasami YamadaNoritaka OyamaMinoru HasegawaPublished in: Arthritis research & therapy (2023)
Our results prove that calpains can be a novel therapeutic target for skin and lung fibrosis in SSc, considering its inhibitor ALLN.